Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Novabio Therapeutics

Clinical trials sponsored by Novabio Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Could your own immune cells fight ALS? early trial begins Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1

Could your own immune cells fight ALS? early trial begins

Disease control Recruiting now

This early-stage trial is testing whether a special type of immune cell, called regulatory T cells (Tregs), is safe for people with ALS. The cells are taken from each patient's own blood, multiplied in a lab, and then injected into the spinal fluid. The study will enroll 12 adult…

Phase 1 • Sponsor: Novabio Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC